Volker Schellenberger is President and CEO of Amunix Operating Inc, which he co-founded with Willem Pim Stemmer in 2006. He initially served as Amunix’ Chief Scientific Officer and is the lead inventor of the company’s XTEN as well as ProTIA platforms. Volker has over 20 years of industry experience in protein engineering and drug discovery. Prior to co-founding Amunix he served as head of Genencor’s protein engineering department.
Volker received his Ph.D. from Leipzig University (Germany) in 1986. After postdoctoral work at the Institute for Protein Research in Pushchino (Russia), the University of Göttingen. and with Bill Rutter at the University of California, San Francisco he joined Genencor in 1994. Volker is author of over 40 scientific papers and inventor of more than 70 issued or pending patent applications. He is a recipient of the Karl Lohmann prize of the German Society of Biochemists.